MAGEA11 and prostate cancer: MAGE-A11 expression is increased during prostate cancer progression and castration-recurrent growth of prostate cancer, which is resulted from the hypomethylation of CpG sites directly proximal to the MAGE-A11 transcription start site (TSS) [54].